ProPhase Labs, Inc. Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
ProPhase Labs, Inc. (PRPH) had Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment of $8.44 million as of 2022-12-31, per its 10-K filed 2023-03-29.
Discontinued › Balance Sheet › Assets › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment · last filed 2023-03-29
- 2022-12-31: Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment $8.44M.
- 2022-09-30: Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment $7.91M.
- 2022-06-30: Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment $7.57M.
- 2022-03-31: Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment $7.37M.
| Period end | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment |
|---|---|
| 2022-12-31 | $8.44M 10-K · filed 2023-03-29 |
| 2022-09-30 | $7.91M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $7.57M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $7.37M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $6.88M 10-K · filed 2023-03-29 |
| 2021-09-30 | $6.40M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $5.92M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $5.45M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $5.02M 10-K · filed 2022-03-31 |
| 2020-09-30 | $4.90M 10-Q · filed 2020-11-19 |
| 2020-06-30 | $6.38M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $6.29M 10-Q · filed 2020-05-12 |
| 2019-12-31 | $6.25M 10-K · filed 2021-03-31 |
| 2019-09-30 | $6.16M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $6.06M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $5.96M 10-Q · filed 2019-05-14 |
| 2018-12-31 | $5.85M 10-K · filed 2020-03-26 |
| 2018-09-30 | $5.76M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $5.66M 10-Q · filed 2018-08-20 |
| 2018-03-31 | $5.57M 10-Q/A · filed 2018-08-20 |
| 2017-12-31 | $5.47M 10-K · filed 2019-03-26 |
| 2017-09-30 | $5.37M 10-Q/A · filed 2018-08-20 |
| 2017-06-30 | $5.27M 10-Q/A · filed 2018-08-20 |
| 2017-03-31 | $5.40M 10-Q/A · filed 2018-08-20 |
| 2016-12-31 | $5.13M 10-Q/A · filed 2018-08-20 |
| 2016-09-30 | $5.03M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $4.92M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $4.82M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $4.71M 10-K · filed 2017-02-24 |
| 2015-09-30 | $4.60M 10-Q · filed 2015-11-13 |
| 2015-06-30 | $4.51M 10-Q · filed 2015-08-12 |
| 2015-03-31 | $4.42M 10-Q · filed 2015-05-13 |
| 2014-12-31 | $4.34M 10-K · filed 2016-03-29 |
| 2014-09-30 | $4.27M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $4.20M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $4.13M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $4.06M 10-K · filed 2015-03-27 |
| 2013-09-30 | $4.00M 10-Q · filed 2013-11-13 |
| 2013-06-30 | $3.98M 10-Q · filed 2013-08-13 |
| 2013-03-31 | $3.92M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $3.86M 10-K · filed 2014-03-27 |
| 2012-09-30 | $3.80M 10-Q · filed 2012-11-14 |
| 2012-06-30 | $3.73M 10-Q · filed 2012-08-13 |
| 2012-03-31 | $3.67K 10-Q · filed 2012-05-11 |
| 2011-12-31 | $3.61M 10-K · filed 2013-03-28 |
| 2011-09-30 | $3.55M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $3.58M 10-Q · filed 2011-08-12 |
| 2010-12-31 | $3.39M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |